What to Know About Ibogaine, a Psychedelicnews2024-03-05T08:00:07+00:00March 5th, 2024|The New York Times|
R.S.V. Vaccines May Slightly Increase Risk of Rare Neurological Conditionnews2024-02-29T22:20:23+00:00February 29th, 2024|The New York Times|
What to Know About Xolair and Food Allergiesnews2024-02-25T18:54:05+00:00February 25th, 2024|The New York Times|
Drug Drastically Reduces Children’s Reactions to Traces of Food Allergensnews2024-02-25T18:45:08+00:00February 25th, 2024|The New York Times|
Gene Therapies Could Transform Rare Diseases. Are We Holding Them Back?news2024-02-19T22:47:36+00:00February 19th, 2024|The New York Times|
Biogen Abandons Its Controversial Alzheimer’s Drug Aduhelmnews2024-01-31T19:10:58+00:00January 31st, 2024|The New York Times|
A Rejected A.L.S. Drug Made Me Rethink the Role of Hope in Medicinenews2023-12-25T14:00:10+00:00December 25th, 2023|The New York Times|
Monica Bertagnolli, NIH’s New Leader, Wants to Broaden Participation in Medical Researchnews2023-12-25T10:00:53+00:00December 25th, 2023|The New York Times|
Can Ozempic and Weight Loss Drugs Treat Other Diseases?news2023-12-20T16:09:05+00:00December 20th, 2023|The New York Times|
New Hope — and an Old Hurdle — for a Terrible Disease With Terrible Treatmentsnews2023-12-19T08:01:00+00:00December 19th, 2023|The New York Times|
